Evidence map›Paper›PMID 33423134›Full record

ArticleEuropean spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society2021

Serum biomarkers for Modic changes in patients with chronic low back pain.

Jaro Karppinen, Katri Koivisto, Jukka Ketola, Marianne Haapea, Markus Paananen, Karl-Heinz Herzig, Mauro Alini, Jeffrey Lotz, Stefan Dudli, Dino Samartzis and 7 more

Abstract read
PubMed Publisher
In one paragraph

Article in European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Challenges and opportunities for omics-based precision medicine in chronic low back pain.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Discovery of circulating blood biomarkers in patients with and without Modic changes of the lumbar spine: a preliminary analysis.European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2024
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Role of C-reactive protein in the bone marrow of Modic type 1 changes.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2023
    Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jaro KarppinenMedical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.
Katri KoivistoMedical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.
Jukka KetolaMedical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.
Marianne HaapeaMedical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.
Markus PaananenMedical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.
Karl-Heinz HerzigMedical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.
Mauro AliniAO Research Institute, Davos, Switzerland.
Jeffrey LotzDepartment of Orthopaedic Surgery, University of California San Francisco, San Francisco, USA.
Stefan DudliCenter of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland.
Dino SamartzisDepartment of Orthopaedic Surgery, RUSH University Medical Center, Suite 204-G, 1611 W. Harrison Street, Orthopaedic BuildingChicago, IL, 60612, USA. dino_samartzis@rush.edu.ORCID 0000-0002-7473-1311
Juha RisteliNorthern Finland Laboratory Centre NordLab, Oulu University Hospital, Oulu, Finland.
Marja-Leena MajuriMedical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.
Harri AleniusInstitute of Environmental Medicine, Karolinska Institute, Stockholm, Sweden.
Eero KyllönenMedical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.
Jyri JärvinenResearch Unit of Medical Imaging, Physics and Technology, Faculty of Medicine, University of Oulu, Oulu, Finland.
Jaakko NiinimäkiMedical Research Center Oulu, Oulu University Hospital and University of Oulu, Oulu, Finland.
Sibylle GradAO Research Institute, Davos, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeLumbar Modic change (MC) can serve as a diagnostic marker as well as an independent source of chronic low back pain (CLBP). This study aimed to test for the existence of serum biomarkers in CLBP patients with MC.

methodsAge- and sex-matched CLBP patients with confirmed MC on lumbar MRI (n = 40) and pain-free controls (n = 40) were assessed. MC was classified into M1, predominating M1, predominating M2 and M2. MC volumes were calculated. Fasting blood samples were assessed for inflammatory mediators, signalling molecules, growth factors and bone turnover markers. Serum concentrations of 46 biomarkers were measured.

resultsMedian concentrations of interleukin (IL)-15 (p < 0.001), IL-8 (p < 0.001), tumour necrosis factor (TNF)-alpha (p < 0.001), Eotaxin-1 (p < 0.05), Eotaxin-3 (p < 0.001), monocyte chemotactic protein (MCP)-1 (p < 0.05), macrophage inflammatory protein (MIP)-1alpha (p < 0.01), TEK receptor tyrosine kinase (Tie)-2 (p < 0.001), vascular cell adhesion molecule (VCAM)-1 (p < 0.001), RANTES (p < 0.001), C telopeptide of type I collagen (CTX)-1 (p < 0.001), vascular endothelial growth factor (VEGF)-C (p < 0.001), VEGF-D (p < 0.05), fms-related tyrosine kinase (Flt)-1 (p < 0.01) and intercellular adhesion molecule (ICAM)-1 (p < 0.01) were significantly higher among controls. IL-1sRII (23.2 vs. 15.5 ng/ml, p < 0.001) and hepatocyte growth factor (HGF)-1 (169 vs. 105 pg/ml, p < 0.01) concentrations were significantly higher among patients. Type or volume of MC was not associated with biomarker concentrations.

conclusionsThis is the first study to assess the blood serum biomarker profile in individuals with CLBP with MC. Several biomarkers were suppressed, while two markers (IL-1sRII and HGF) were elevated among MC patients, irrespective of MC type or size, with CLBP compared with asymptomatic controls.

Indexed as

Low Back PainBiomarkersHumansInflammation MediatorsLumbosacral RegionVascular Endothelial Growth Factor ABiomarkersInflammation MediatorsVascular Endothelial Growth Factor ABiomarkersChronic low back painMagnetic resonance imagingModic changeSerumZoledronic acid

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.